Shannon Carpenter
Pediatric Hematology-Oncology · Kansas City, MONPI 1730296716
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (56.8%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Novo Nordisk at 32.9% of the total. Reporting peaked in 2023 at $8,367 and has fallen 89.9% since, to $844 in 2025.
Across 45 payments — averaging $411.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$6K
- Genentech, Inc.$5K
- Genentech USA, Inc.$4K
- CSL Behring$2K
- Sanofi$909
- Octapharma USA, Inc.$107
- plus $109 from 3 others
Across 39 payments — averaging $86,181 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi$2.6M
- CSL Behring$593K
- Pfizer$125K
- Genentech, Inc.$38K
- F. Hoffmann-la Roche AG$19K
- Bayer$6K
- plus $2K from 1 others
What the payments were for
- Consulting fees$10,51057%
- Speaking & faculty fees$4,53625%
- Grants$991%
- Travel & lodging$3902%
- Food & beverage$2,96916%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 4 | $6,083 |
| Genentech, Inc. | 9 | $5,255 |
| Genentech USA, Inc. | 14 | $3,785 |
| CSL Behring | 3 | $2,256 |
| Sanofi | 11 | $909 |
| Octapharma USA, Inc. | 1 | $107 |
| Kedrion Biopharma Inc. | 1 | $73 |
| Pfizer | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$18,504 in reported general payments places this provider in the 85th percentile of 78 pediatric hematology-oncology providers in Missouri.
See all pediatric hematology-oncology providers in Missouri →
Other pediatric hematology-oncology in Kansas City
- Michael SilveyKansas City$124K
- Lauren AmosKansas City$109K
- Ibrahim AhmedKansas City$79K
- Erin GuestKansas City$21K
- Gerald WoodsKansas City$11K
- Brian WicklundKansas City$9K
- Keith AugustKansas City$7K
- Terrie FlattKansas City$5K
- Jignesh DalalKansas City$4K
- Sara McElroyKansas City$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.